Health Catalyst第四季度调整后每股收益为$0.04,不及预期的$0.07,销售额为$79.61M,不及预期的$79.67M

财报速递2025-02-27
Health Catalyst (NASDAQ: HCAT)报告季度每股收益为$0.04,不及分析师一致预期的$0.07,差距为42.86%。这较去年同期的每股收益$0.02相比增长了100%。公司报告季度销售额为$79.61百万,不及分析师一致预期的$79.67百万,差距为0.08%。这较去年同期的销售额$75.08百万相比增长了6.02%。

以上内容来自Benzinga Earnings专栏,原文如下:

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is a 100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $79.61 million which missed the analyst consensus estimate of $79.67 million by 0.08 percent. This is a 6.02 percent increase over sales of $75.08 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法